NCT01498861View on ClinicalTrials.gov

Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Infection, Human Immunodeficiency Virus
Interventions
DRUG

Ortho-Cyclen

Ortho-cyclen is an oral contraceptive.

DRUG

Dolutegravir

Dolutegravir is an experimental HIV drug

DRUG

Placebo

Placebo is a tablet with no drug in it

Trial Locations (1)

33169

GSK Investigational Site, Miami

Sponsors

Lead Sponsor

ViiV Healthcare

Collaborators (2)

Shionogi
GlaxoSmithKline
All Listed Sponsors
collaborator

Shionogi

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

lead

ViiV Healthcare

INDUSTRY

NCT01498861 - Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol | Biotech Hunter | Biotech Hunter